TME PHARMA NV (ALTME.PA)

NL0015000YE1 - Common Stock

0.07  0 (-4.11%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-6-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
0.000.001.00K0.000.00
Operating Expenses
4.55M4.82M12.01M13.46M5.82M
Research and Development
2.44M2.65M8.15M10.66M4.02M
Selling, General, and Administrative Expenses
2.11M2.19M3.88M2.88M1.88M
Operating Income
-4.55M-4.82M-12.01M-13.46M-5.82M
Interest Income/Expense
-698.00K-1.50M-3.31M-1.28M-4.92M
Other Income/Expense
-15.00K395.00K181.00K270.00K300.00K
Non Recurring Items
-1.06M-804.00K18.00K10.00K40.00K
Income Before Taxes
-6.32M-6.73M-15.13M-14.45M-10.41M
Income Tax
N/A2.00K7.00K0.000.00
Net Income
-6.33M-6.74M-15.13M-14.45M-10.41M
EBITDA
-4.42M-4.68M-11.92M-13.39M-5.76M
 
Per Share Data
EPS Diluted Total Ops
-0.58-1.34-12.86-21.90-32.53
 
Statistics
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in EUR

Charts